Hemelaar J., Elangovan R., Yun J., Dickson-Tetteh L., Fleminger I., Kirtley S., Williams B., Gouws-Williams E., Ghys P.D. Global and regional molecular epidemiology of HIV-1, 1990–2015: a systematic review, global survey, and trend analysis // The Lancet Infectious Diseases. 2018. Vol. 19, No. 2. P. 143–155.

Thompson R. Pandemic potential of 2019-nCoV // Lancet Infect Dis. 2020. Vol. 20, No. 3. Р. 280. https://doi.org/10.1016/S1473-3099(20)30068-2..
DOI: 10.1016/S1473-3099(20)30068-2

Kanwugu О.N., Adadi Р. HIV/SARS-CoV-2 coinfection: A global perspective // Journal of Medical Virology. 2021. Vol. 93, No. 2. P. 726–732. https://doi.org/10.1002/jmv.26321..
DOI: 10.1002/jmv.26321

Barbera L.K., Kevin F. Kamis K.F., Rowan S.E., Davis A.J., Shehata S., Carlson J.J., Johnson S.C., Erlandson K.M. HIV and COVID-19: review of clinical course and outcomes // HIV Research & Clinical Practice. 2021. Published online. doi: 10.1080/25787489.2021.1975608..
DOI: 10.1080/25787489.2021.1975608

Лесина О.Н., Гущин О.А., Кумарева Д.Ю. Клинико-лабораторные особенности пациентов при коинфекции HIV и SARS-CoV-2 // Журнал инфектологии. 2021. Т. 13, № 3. С. 148–149.

Eggers C., Arendt G., Hahn K. et al. HIV-1-associated neurocognitive disorder: epidemiology, pathogenesis, diagnosis, and treatment // J. Neurol. 2017. Vol. 264. Р. 1715–1727. https://doi.org/10.1007/s00415-017-8503-2..
DOI: 10.1007/s00415-017-8503-2

Wang Y., Liu M., Lu Q., Farrell F., Lappin J.M., Shi J., Lu L., Bao Y. Global prevalence and burden of HIV-associated neurocognitive disorder. A meta-analysis // Neurology. 2020. Vol. 95, No. 19. e2610-e2621.

Евзельман М.А., Снимщикова И.А., Королев Л.Я., Камчатнов П.Р. Неврологические осложнения ВИЧ-инфекции // Журнал неврологии и психиатрии. 2015. № 3. С. 89–93.

Тибекина Л.М., Малько В.А., Флуд В.В., Лепилина А.В. Церебральные инсульты у больных с ВИЧ-инфекцией // ВИЧ-инфекция и иммуносупрессии. 2019. Т. 11, № 4. С. 51–59.

Centner C.M., Bateman K.J., Heckmann J.M. Manifestations of HIV infection in the peripheral nervous system // The Lancet Neurology. 2013. Vol. 12, No. 3. P. 295–309. https://doi.org/10.1016/S1474-4422(13)70002-4..
DOI: 10.1016/S1474-4422(13)70002-4

Gonzalez-Duarte A., Cikurel K., Simpson D.M. Managing HIV peripheral neuropathy // Current HIV/AIDS. 2007. Rep. 4. Р. 114–118. https://doi.org/10.1007/s11904-007-0017-6..
DOI: 10.1007/s11904-007-0017-6

Беляков Н.А., Медведев С.В., Трофимова Т.Н., Рассохин В.В., Дементьева Н.Е., Шеломов А.С. Механизмы поражения головного мозга при ВИЧ-инфекции // Вестник РАМН. 2012. № 9. C. 4–12.

Putatunda R., Ho W.Z., Hu W. HIV-1 and Compromised Adult Neurogenesis: Emerging Evidence for a New Paradigm of HAND Persistence // AIDS Reviews. 2019. Vol. 21, No. 1. Р. 11–22. doi: 10.24875/AIDSRev.19000003..
DOI: 10.24875/AIDSRev.19000003

Filatov A., Sharma P., Hindi F., Espinosa P.S. Neurological complications of coronavirus disease (COVID-19): encephalopathy // Cureus. 2020. Vol. 12, No. 3. e7352. https://doi.org/10.7759/cureus.7352..
DOI: 10.7759/cureus.7352

Aghagoli G., Gallo Marin B., Katchur N.J., Chaves-Sell F., Asaad W.F., Murphy S.A. Neurological Involvement in COVID-19 and Potential Mechanisms: A Review // Neurocrit. Care. 2021. Jun. Vol. 34, No. 3. Р. 1062–1071. doi: 10.1007/s12028-020-01049-4..
DOI: 10.1007/s12028-020-01049-4

Беляков Н.А., Рассохин В.В. ВИЧ-инфекция и коморбидные состояния. СПб., 2020. 680 с.: ил. [Belyakov N.A., Rassokhin V.V. HIV infection and comorbid conditions. St. Petersburg, 2020. 680 p.: ill. (In Russ.)].

Yazdanpanah N., Rezaei N. Autoimmune complications of COVID-19 // Journal of Medical Virology. 2022. Jan. Vol. 94, No. 1. Р. 54–62. doi: 10.1002/jmv.27292..
DOI: 10.1002/jmv.27292

Mao L., Jin H., Wang M. et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China // JAMA Neurol. 2020. Vol. 77, No. 6. Р. 683–690.

Cagnazzo F., Arquizan C., Derraz I. et al. Neurological manifestations of patients infected with the SARS-CoV-2: A systematic review of the literature // J. Neurol. 2020. Vol. 15. Р. 3.

Ghannam M., Alshaer Q., Al-Chalabi M. et al. Neurological involvement of coronavirus disease 2019: A systematic review // J. Neurol. 2020. Vol. 267, No. 11. Р. 3135–3153.

Wrapp D., Wang N., Corbett K.S., Goldsmith J.A., Hsieh C.L., Abiona O., Graham B.S., McLellan J.S. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation // Science. 2020. Mar 13. Vol. 367, No. 6483. Р. 1260–1263. doi: 10.1126/science.abb2507..
DOI: 10.1126/science.abb2507

Villarreal I.M., Morato M., Martinez-RuizCoello M. et al. Olfactory and taste disorders in healthcare workers with COVID-19 infection // Eur. Arch. Otorhinolaryngol. 2021. Vol. 278, No. 6. Р. 2123–2127.

Yan C.H., Faraji F., Prajapati D.P. et al. Association of chemosensory dysfunction and COVID-19 in patients presenting with influenza-like symptoms // Int. Forum Allergy Rhinol. 2020. Vol. 10, No. 7. Р. 806–813.

Suzuki Y., Takeda M., Obara N. et al. Olfactory epithelium consisting of supporting cells and horizontal basal cells in the posterior nasal cavity of mice // Cell Tissue Res. 2000. Vol. 299, No. 3. Р. 313–325.

Liang F. Sustentacular cell enwrapment of olfactory receptor neuronal dendrites: An update // Genes (Basel). 2020. Vol. 11, No. 5. Р. 493.

Bilinska K., Jakubowska P., Von Bartheld C.S., Butowt R. Expression of the SARS-CoV-2 entry proteins, ACE2 and TMPRSS2, in cells of the olfactory epithelium: Identification of cell types and trends with age // ACS Chem Neurosci. 2020. Vol. 11, No. 11. Р. 1555–1562.

Bryche B., St Albin A., Murri S. et al. Massive transient damage of the olfactory epithelium associated with infection of sustentacular cells by SARS-CoV-2 in golden Syrian hamsters // Brain Behav Immun. 2020. Vol. 89. Р. 79–86.

Yachou Y., El Idrissi A., Belapasov V., Ait Benali S. Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients // Neurological Sciences. 2020. Vol. 41. Р. 2657–2669. doi 10.1007/s10072-020-04575-3.

Meinhardt J., Radke J., Dittmayer C. et al. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19 // Nat Neurosci. 2021. Vol. 24, No. 2. Р. 168–175.

Bulfamante G., Chiumello D., Canevini M.P. et al. First ultrastructural autoptic findings of SARS — Cov-2 in olfactory pathways and brainstem // Minerva Anestesiol. 2020. Vol. 86, No. 6. Р. 678–679.

Aragao M., Leal M.C., Cartaxo Filho O.Q. et al. Anosmia in COVID-19 associated with injury to the olfactory bulbs evident on MRI // Am. J. Neuroradiol. 2020. Vol. 41, No. 9. Р. 1703–1706.

Politi L.S., Salsano E., Grimaldi M. Magnetic resonance imaging alteration of the brain in a patient with coronavirus disease 2019 (COVID-19) and anosmia // JAMA Neurol. 2020. Vol. 77, No. 8. Р. 1028–1029.

Von Weyhern C.H., Kaufmann I., Neff F., Kremer M. Early evidence of pronounced brain involvement in fatal COVID-19 outcomes // Lancet. 2020. Vol. 395, No. 10241. Р. e109.

Bulfamante G., Bocci T., Falleni M. et al. Brainstem neuropathology in two cases of COVID-19: SARS-CoV-2 trafficking between brain and lung // J. Neurol. 2021.

Lima M., Siokas V., Aloizou A.M. et al. Unraveling the possible routes of SARS-CoV-2 invasion into the central nervous system // Curr. Treat Options Neurol. 2020. Vol. 22, No. 11. Р. 37.

Dahiya D.S., Kichloo A., Albosta M., Pagad S., Wani F. Gastrointestinal implications in COVID-19 // J. Investig Med. 2020. Dec. Vol. 68, No. 8. Р. 1397–1401. doi: 10.1136/jim-2020-001559..
DOI: 10.1136/jim-2020-001559

Satarker S., Nampoothiri M. Involvement of the nervous system in COVID-19: The bell should toll in the brain // Life Sci. 2020. Vol. 262. Р. 118568.

McCray P.B. Jr., Pewe L., Wohlford-Lenane C. et al. Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus // J. Virol. 2007. Vol. 81, No. 2. Р. 813–821.

Pezzini A., Padovani A. Lifting the mask on neurological manifestations of COVID-19 // Nat. Rev. Neurol. 2020. Vol. 16, No. 11. Р. 636–644.

Baig A.M., Khaleeq A., Ali U., Syeda H. Evidence of the COVID-19 virus targeting the CNS: Tissue distribution, host-virus interaction, and proposed neurotropic mechanisms // ACS Chem Neurosci. 2020. Vol. 11, No. 7. Р. 995–998.

Buzhdygan T.P., DeOre B.J., Baldwin-Leclair A. et al. The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in vitro models of the human blood-brain barrier // Neurobiol. Dis. 2020. Vol. 146. Р. 105131.

Torices S., Cabrera R., Stangis M., Naranjo O., Fattakhov F., Teglas T. et al. Expression of SARS-CoV-2-related receptors in cells of the neurovascular unit: implications for HIV-1 infection // Journal of Neuroinflammation. 2021. Vol. 18. Р. 167. https://doi.org/10.1186/s12974-021-02210-2..
DOI: 10.1186/s12974-021-02210-2

Hu J., Jolkkonen J., Zhao C. Neurotropism of SARS-CoV-2 and its neuropathological alterations: Similarities with other coronaviruses // Neurosci Biobehav Rev. 2020. Vol. 119. Р. 184–193.

Izquierdo-Useros N., Naranjo-Gomez M., Erkizia I. et al. HIV and mature dendritic cells: Trojan exosomes riding the Trojan horse? // PLoS Pathog. 2010. Vol. 6, No. 3. Р. e1000740.

Bao L., Deng W., Huang B. et al. The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice // Nature. 2020. Vol. 583, No. 7818. Р. 830–833.

Беляков Н.А., Багненко С.Ф., Рассохин В.В., Трофимова Т.Н. и др. Эволюция пандемии COVID-19. CПб.: Балтийский медицинский образовательный центр, 2021. 410 с.: ил.

Paniz-Mondolfi A., Bryce C., Grimes Z. et al. Central nervous system involvement by severe acute respiratory syndrome coronavirus-2 (SARSCoV-2) // J. Med. Virol. 2020. Vol. 92, No. 7. Р. 699–702.

Hoogland I.C., Houbolt C., van Westerloo D.J., van Gool W.A., van de Beek D. Systemic inflammation and microglial activation: systematic review of animal experiments // J. Neuroinflammation. 2015. Jun. 6. Vol. 12. Р. 114. doi: 10.1186/s12974-015-0332-6..
DOI: 10.1186/s12974-015-0332-6

Dandekar A.A., Wu G.F., Pewe L., Perlman S. Axonal damage is T cell mediated and occurs concomitantly with demyelination in mice infected with a neurotropic coronavirus // J. Virol. 2001. Vol. 75, No. 13. Р. 6115–6120.

Septyaningtrias D.E., Susilowati R. Neurological involvement of COVID-19: From neuroinvasion and neuroimmune crosstalk to long-term consequences // Rev. Neurosci. 2021. Vol. 32, No. 4. Р. 427–442.

Mukandala G., Tynan R., Lanigan S., O’Connor J.J. The effects of hypoxia and inflammation on synaptic signaling in the CNS // Brain Sci. 2016. Vol. 6, No. 1. Р. 6.

Ferraro E., Germano M., Mollace R. et al. HIF-1, the Warburg effect, and macrophage/microglia polarization potential role in COVID-19 pathogenesis // Oxid. Med. Cell Longev. 2021. Vol. 2021. Р. 8841911.

Xu J., Lazartigues E. Expression of ACE2 in Human Neurons Supports the Neuro-Invasive Potential of COVID-19 Virus // Cell Mol. Neurobiol. 2022. Jan. Vol. 42, No. 1. Р. 305–309. doi: 10.1007/s10571-020-00915-1..
DOI: 10.1007/s10571-020-00915-1

Wang T., Town T., Alexopoulou L., Anderson J.F., Fikrig E., Flavell R.A. Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis // Nat. Med. 2004. Vol. 10. Р. 1366–1373.

Белопасов В.В., Яшу Я., Самойлова Е.М., Баклаушев В.П. Поражение нервной системы при COVID-19. 2020..
DOI: 10.17816/clinpract34851

Ellul M.A., Benjamin L., Singh B., Lant S., Michael B.D., Easton A., Kneen R., Defres S., Sejvar J., Solomon T. Neurological associations of COVID-19 // Lancet Neurol. 2020. https://doi.org/10.1016/S1474-4422(20)30221-0..
DOI: 10.1016/S1474-4422(20)30221-0

Abu-Rumeileh S., Abdelhak A., Foschi M., Tumani H., Otto M. Guillain-Barr´e syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases // J. Neurol. 2020. https://doi.org/10.1007/s00415-020-10124-x..
DOI: 10.1007/s00415-020-10124-x

Puelles V.G., Lütgehetmann M., Lindenmeyer M.T., Sperhake J.P., Wong M.N. Multiorgan and renal tropism of SARS-CoV-2 // N. Engl. J. Med. 2020. Vol. 383. Р. 590–592.

Wichmann D., Sperhake J.-P., Lütgehetmann M., Steurer S., Edler C., Heinemann A., Heinrich F., Mushumba H. Autopsy findings and venous thromboembolism in patients with COVID-19: a prospective cohort study // Ann. Intern. Med. 2020. Vol. 173. Р. 268–277.

Matschke J., Lütgehetmann M., Hagel C., Sperhake J.P., Schr¨oder A.S., Edler C., Mushumba H., Dottermusch M. Neuropathology of patients with COVID-19 in Germany: a post-mortem case series // Lancet Neurol. 2020. Vol. 19. Р. 919–929.

Solomon I.H., Normandin E., Bhattacharyya S., Mukerji S.S., Keller K., Ali A.S. Neuropathological features of Covid-19 // N. Engl. J. Med. 2020. https://doi.org/10.1056/NEJMc2019373..
DOI: 10.1056/NEJMc2019373

Remmelink M., De Mendonça R., D’Haene N., De Clercq S., Verocq C., Lebrun L., Salmon I. Unspecific postmortem findings despite multiorgan viral spread in COVID-19 patients // Crit. Care. 2020. Vol. 24. Р. 495.

Shibani S., Mukerji A., Solomon I.H. What can we learn from brain autopsies in COVID-19? // Neuroscience Letters. 2021. Vol. 742. Р. 135528.

Serrano G.E., Walkera J.E., Arcea R., Glassa M.J., Vargasa D., Lucia I. Suea L.I. Mapping of SARS-CoV-2 Brain Invasion and Histopathology in COVID-19 Disease. 2021. https://doi.org/10.1101/2021.02.15.21251511..
DOI: 10.1101/2021.02.15.21251511

Rhodes R.H., Love G.L., Da Silva Lameira F. et al. Acute Endotheliitis (Type 3 Hypersensitivity Vasculitis) in Ten COVID-19 Autopsy Brains. medRxiv. 2021.

Butowt R., Bilinska K. SARS-CoV-2: Olfaction, Brain Infection, and the Urgent Need for Clinical Samples Allowing Earlier Virus Detection // ACS Chem. Neurosci. 2020.

Politis C., Papadaki M., Politi L. et al. Post-donation information and haemovigilance reporting for COVID-19 in Greece: Information supporting the absence of SARS-CoV-2 possible transmission through blood components. Transfus Clin Biol. 2020.

Rosin N.L., Jaffer A., Sinha S. et al. SARS-CoV-2 infection of circulating immune cells is not responsible for virus dissemination in severe COVID-19 patients. bioRxiv. 2021.

Andersson M.I., Arancibia-Carcamo C.V., Auckland K. et al. SARS-CoV-2 RNA detected in blood products from patients with COVID-19 is not associated with infectious virus. Wellcome Open Res. 2020. Vol. 5:181.

Payus A.O., Jeffree M.S., Ohn M.H., Tan H.J., Ibrahim A., Chia Y.K., Raymond A.A. Immune-mediated neurological syndrome in SARS-CoV-2 infection: a review of literature on autoimmune encephalitis in COVID-19 // Neurol Sci. 2022. Mar. Vol. 43, No. 3. Р. 1533–1547. doi: 10.1007/s10072-021-05785-z..
DOI: 10.1007/s10072-021-05785-z

Marchioni E., Ravaglia S., Montomoli C. et al. Postinfectious neurologic syndromes // A prospective cohort study. 2013. Vol. 80, No. 10. Р. 882–889.

Van den Berg B., Walgaard C. et al. Guillain-Barre syndrome: Pathogenesis, diagnosis, treatment and prognosis // Nat. Rev. Neurol. 2014. Vol. 10, No. 8. Р. 469–482.

Li Z., Huang Z., Li X. et al. Bioinformatic analyses hinted at augmented T helper 17 cell differentiation and cytokine response as the central mechanism of COVID-19-associated Guillain-Barre syndrome // Cell Prolif. 2021. Vol. 54, No. 5. Р. e13024.

Kleyweg R.P., van der Meche F.G.A., Meulstee J. Treatment of Guillain-Barre syndrome with high-dose gammaglobulin // Neurology. 1988. Oct. Vol. 38, No. 10. Р. 1639–1641.

Orlikowski D., Porcher R., Sivadon Tardy V. et al. Guillain-Barré syndrome following primary cytomegalovirus infection: a prospective cohort study // Clin. Infect. Dis 2011. Vol. 52. Р. 837–844.

Brannagan T.H. 3rd, Zhou Y. HIV-associated Guillain-Barré syndrome // J. Neurol. Sci. 2003. Apr 15. Vol. 208, No. 1–2. Р. 39–42. doi: 10.1016/s0022–510x(02)00418–5. PMID: 12639723..
DOI: 10.1016/s0022–510x(02)00418–5

Islam Z., Jacobs B.C., van Belkum A. et al. Axonal variant of Guillain-Barre syndrome associated with Campylobacter infection in Bangladesh // Neurology. 2010. Feb. 16. Vol. 74, No. 7. Р. 581–587. doi: 10.1212/WNL.0b013e3181cff735. PMID: 20157160..
DOI: 10.1212/WNL.0b013e3181cff735

van den Berg B., van der Eijk A.A., Pas S.D. et al. Guillain-Barré syndrome associated with preceding hepatitis E virus infection // Neurology. 2014 Feb 11. Vol. 82, No. 6. Р. 491–497. doi: 10.1212/WNL.0000000000000111. Epub 2014 Jan 10. PMID: 24415572..
DOI: 10.1212/WNL.0000000000000111. Epub 2014 Jan 10

Uncini A., Shahrizaila N., Kuwabara S. Zika virus infection and Guillain-Barré syndrome: a review focused on clinical and electrophysiological subtypes // Journal of Neurology, Neurosurgery & Psychiatry. 2017. Vol. 88. Р. 266–271.

Donofrio P.D. Guillain-Barre´ syndrome. Continuum (Minneap, Minn). 2017. Vol. 23, No. 5. Peripheral Nerve and Motor Neuron Disorders. Р. 1295–1309. https://doi.org/10.1212/ CON.0000000000000513..
DOI: 10.1212/ CON.0000000000000513

Heikema A.P., Islam Z., Horst-Kreft D. et al. Campylobacter jejuni capsular genotypes are related to Guillain-Barré syndrome // Clin. Microbiol. Infect. 2015. Sep. Vol. 21, No. 9. Р. 852.e1–9. https://doi.org/10.1016/j.cmi.2015.05.031.
DOI: 10.1016/j.cmi.2015.05.031